The Digital Health M&A Wave Is Finally Here

Digital health is entering a more mature phase in 2026 as consolidation accelerates through targeted M&A, driven by the need for scale, artificial intelligence and pressure from payers, investors say. The post The Digital Health M&A Wave Is Finally Here appeared first on MedCity News.

Read More

Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials

Eikon Therapeutics’ IPO haul will support a lead program that could expand the scope of cancer immunotherapy. Eikon’s stock market debut builds on growing IPO momentum, following upsized offerings from Aktis Oncology and Veradermics. The post Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials appeared first on MedCity News.

Read More

Debunked Episode 23: Companies Vie for Healthcare AI Dominance

The conversation between MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, highlighted news from the J.P. Morgan Healthcare Conference, particularly how technology and biopharma companies are shaping AI in healthcare. The post Debunked Episode 23: Companies Vie for Healthcare AI Dominance appeared first on MedCity News.

Read More